JACC: Heart Failure

Journal

Publication Venue For

  • Periodontal Status, C-Reactive Protein, NT-proBNP, and Incident Heart Failure: The ARIC Study.  10:731-741. 2022
  • A Clinical Framework for Evaluating Machine Learning Studies.  10:648-650. 2022
  • Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults.  10:129-138. 2022
  • Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS.  9:736-746. 2021
  • REVeAL-HF: Design and Rationale of a Pragmatic Randomized Controlled Trial Embedded Within Routine Clinical Practice.  9:409-419. 2021
  • Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure.  9:192-200. 2021
  • Worsening Kidney Function Is the Major Mechanism of Heart Failure in Hypertension: The ALLHAT Study.  9:100-111. 2021
  • Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community.  8:640-653. 2020
  • Reply: Toward Improved Understanding of Potential Harm in Heart Failure.  8:247-248. 2020
  • Prescribing Patterns of Heart Failure-Exacerbating Medications Following a Heart Failure Hospitalization.  8:25-34. 2020
  • Heart Failure Prevention in Older Patients Using Intensive Blood Pressure Reduction: Potential Role of Diuretics.  7:1032-1041. 2019
  • Impact of Malnutrition Using Geriatric Nutritional Risk Index in Heart Failure With Preserved Ejection Fraction.  7:664-675. 2019
  • Association of Urine Albumin Excretion With Incident Heart Failure Hospitalization in Community-Dwelling Adults.  7:394-401. 2019
  • Physical Activity and Incidence of Heart Failure in Postmenopausal Women.  6:983-995. 2018
  • Caregivers of Patients Considering a Destination Therapy Left Ventricular Assist Device and a Shared Decision-Making Intervention: The DECIDE-LVAD Trial.  6:904-913. 2018
  • Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial.  6:689-697. 2018
  • Trends and Cost of Heart Transplantation and Left Ventricular Assist Devices: Impact of Proposed Federal Cuts.  6:424-432. 2018
  • INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices: Risk Factors and Outcomes.  5:703-711. 2017
  • Discordant Perceptions of Prognosis and Treatment Options Between Physicians and Patients With Advanced Heart Failure.  5:663-671. 2017
  • Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial.  5:241-252. 2017
  • Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload: The ARIC Study.  5:157-165. 2017
  • Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.  4:333-344. 2016
  • Reply: Upgrade Ambulatory Extra-Aortic Counterpulsation to Full-Support LVAD.  3:343-344. 2015
  • Adverse left ventricular remodeling incommunity-dwelling older adults predicts incident heart failure and mortality.  2:512-522. 2014
  • Ambulatory extra-aortic counterpulsation in patients with moderate to severe chronic heart failure.  2:526-533. 2014
  • Heart failure risk across the spectrumofankle-brachial index: The ARIC study (Atherosclerosis RiskIn Communities).  2:447-454. 2014
  • Left ventricular size, mass, and shape: Is the sum greater than the parts?.  2:523-525. 2014
  • Effects of exercise training on outcomes inwomen with heart failure. Analysis of HF-ACTION (Heart failure-a controlled trialinvestigating outcomes of exercise training) by Sex.  2:180-186. 2014
  • Functional Status and Outcome After Coronary Artery Bypass Grafting.  2:344-346. 2014
  • Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction.  2:123-130. 2014
  • Insulin Resistance and Incident Heart Failure. The ARIC Study (Atherosclerosis Risk in Communities)..  1:531-536. 2013
  • Heart failure with preserved ejection fraction in african americans. The ARIC (Atherosclerosis risk in communities) study.  1:156-163. 2013
  • Aldosterone antagonists and outcomes in real-world older patients with heart failure and preserved ejection fraction.  1:40-47. 2013

    • International Standard Serial Number (issn)

  • 2213-1779